ROLE OF BIOLOGICAL THERAPY IN ROTATOR CUFF TENDINOPATHY. EFFECTIVENESS OF PLASMA RICH IN GROWTH FACTOR (PRGF-ENDORET)REGARDING TO FUNCTIONAL CAPACITY AND PAIN COMPARED WITH THE CONVENTIONAL TREATMENT USING STEROIDS

FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS0 个研究点目标入组 84 人开始时间: 2013年8月14日最近更新: 2019年2月28日

试验速览

暂无简介。

•Patients between 40 and 70 years old
•Male and female
•Mild to severe symptoms according to the QuickDASH scale over 3 months of evolution.
•Patients with tendinitis, inflammatory or calcium, tendinosis or partial tears of the rotator cuff, diagnosed by ultrasound, evaluated by an expert radiologist independent of the research team.
•Patients refractory to the conservative treatment.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 42
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 42

•Patients with complete tear of the rotator cuff diagnosed by ultrasound or MRI.
•Patients who have previously received treatment with corticoids infiltrations in the last 6 months.
•Patients with arterial hypertension or diabetes mellitus poorly controlled.
•Patients allergic to some of the medicines in the study or some of their excipients.
•Patients treated with anticoagulants or antiplatelet that could not be stopped temporarily for the study.
•Inability to understand health questionnaires and / or complete them properly.
•Patients uncapable to give informed consent.
•Fertile women that do not have a negative pregnancy test before being included in the study.
•Breastfeeding women.

发起方

FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS